September 19, 2013

Honeywell Announces Cylinder Return Deadline For Oxyfume® 2000 Ethylene Oxide Sterilant Blends

Customers should return cylinders by November 1, 2013, to avoid high costs of cylinder disposal


MORRIS TOWNSHIP, N.J., Sept. 19, 2013 – Honeywell (NYSE: HON) announced today a November 1, 2013, deadline for receiving returned cylinders of Oxyfume® 2000 ethylene oxide sterilant blends.

Honeywell announced in August 2012 that it plans to end production of its hospital and laboratory equipment sterilants at the end of 2013. The phaseout is in response to U.S. Clean Air Act regulations, which ban the sale and use of most HCFC-based products like Oxyfume in the U.S. as of Dec. 31, 2014.

“Time is running out for hospitals, laboratories and their distributors to return Oxyfume 2000 cylinders to Honeywell,” said Jeff Czarnecki, global business director for Honeywell’s Healthcare and Packaging business. “Even if customers have already stopped using Oxyfume 2000, they should confirm all cylinders have been returned.”

Current and former customers are encouraged to check for unused Oxyfume 2000 cylinders in their facilities and visit for return information. Cylinders of Oxyfume 12, a CFC-based product phased out in 1995, and Oxyfume 2002, an HCFC-based product phased out in 2009, cannot be received by Honeywell. Current and former customers should contact Honeywell for information on how to handle these cylinders.

Honeywell noted that it can cost more than $1,000 per cylinder to dispose of unused cylinders that are deemed hazardous waste.

For more than 40 years, Oxyfume ethylene oxide sterilant blends have been widely used by hospitals, laboratories and medical device manufacturers. It is estimated that more than 70 percent of hospitals in the United States have used Oxyfume in their sterilization facilities.


Performance Materials and Technologies is a global leader in developing and manufacturing advanced materials and process technologies. These materials and technologies are used by people every day in a wide range of industries and applications, from petroleum refining to environmentally friendlier refrigerants to bullet-resistant vests. Our advanced materials are critical in the manufacture of products ranging from nylon to computer chips to pharmaceutical packaging. Process technologies developed by our UOP business form the foundation for most of the world’s refiners, efficiently producing gasoline, diesel, jet fuel and petrochemicals. UOP is now pioneering technology to produce real fuels from renewable energy sources.


Honeywell ( is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; turbochargers; and performance materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit


This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

# # #